Basuni Ahmed Sobhy
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Tanta University, Tanta, Egypt.
J Anaesthesiol Clin Pharmacol. 2016 Jan-Mar;32(1):44-8. doi: 10.4103/0970-9185.173322.
Spinal anesthesia for cesarean section (CS) is associated with an incidence of hypotension of 60-94%. This study hypothesizes that intrathecal combination of low-dose ketamine, midazolam, and low-dose bupivacaine improves hemodynamics and postoperative analgesia compared with fentanyl and low-dose bupivacaine during CS.
Fifty parturients undergoing elective CS were randomized equally to receive ketamine (10 mg), midazolam (2 mg) and 0.5% hyperbaric bupivacaine (8 mg) in group ketamine-midazolam-bupivacaine (KMB) or fentanyl (25 μg) and 0.5% hyperbaric bupivacaine (8 mg) in group fentanyl-bupivacaine (FB). Heart rate (HR), mean arterial blood pressure (MAP), oxygen saturation, sensorimotor block characteristics, pain-free period, side-effects including: hypotension, bradycardia, nausea, vomiting, sedation, pruritus, respiratory depression and dissociative manifestations, Apgar score at 1 and 5 min, and patients' satisfaction visual analog scores (VAS) were recorded. Patients in group KMB were followed for 6 months in order to assess any neurological disorder.
Group KMB showed higher sensory level (P = 0.006), rapid sensory (P = 0.001) and motor (P = 0.005) onsets, prolonged sensory (P = 0.008) and motor (P = 0.002) blocks, and prolonged pain free period (P = 0.002). Ketamine-midazolam stabilized HR and MAP, and significantly reduced incidence of hypotension (P = 0.002), bradycardia (P = 0.013) and vomiting (P = 0.019). Apgar scores at 1 and 5 min were comparable in both groups (P = 0.699 and 0.646 respectively). Patients' satisfaction VAS scores were significantly higher in group KMB (P = 0.001). No patients in KMB group showed dissociative or neurotoxic manifestations.
Intrathecal low-dose ketamine combined with midazolam and low-dose bupivacaine stabilizes hemodynamics and prolongs postoperative analgesia without significant side-effects in parturients undergoing CS.
剖宫产脊髓麻醉的低血压发生率为60% - 94%。本研究假设,与剖宫产术中使用芬太尼和低剂量布比卡因相比,鞘内注射低剂量氯胺酮、咪达唑仑和低剂量布比卡因可改善血流动力学并增强术后镇痛效果。
50例行择期剖宫产的产妇被平均随机分为两组,氯胺酮 - 咪达唑仑 - 布比卡因组(KMB组)接受氯胺酮(10毫克)、咪达唑仑(2毫克)和0.5%高压布比卡因(8毫克),芬太尼 - 布比卡因组(FB组)接受芬太尼(25微克)和0.5%高压布比卡因(8毫克)。记录心率(HR)、平均动脉压(MAP)、血氧饱和度、感觉运动阻滞特征、无痛期、副作用,包括:低血压、心动过缓、恶心、呕吐、镇静、瘙痒、呼吸抑制和分离表现、1分钟和5分钟时的阿氏评分,以及患者满意度视觉模拟评分(VAS)。对KMB组患者随访6个月以评估是否有任何神经功能障碍。
KMB组感觉平面更高(P = 0.006),感觉(P = 0.001)和运动(P = 0.005)起效更快,感觉(P = 0.008)和运动(P = 0.002)阻滞时间延长,无痛期延长(P = 0.002)。氯胺酮 - 咪达唑仑可稳定HR和MAP,并显著降低低血压(P = 0.002)、心动过缓(P = 0.013)和呕吐(P = 0.019)的发生率。两组1分钟和5分钟时的阿氏评分相当(分别为P = 0.699和P = 0.646)。KMB组患者满意度VAS评分显著更高(P = 0.001)。KMB组无患者出现分离或神经毒性表现。
鞘内注射低剂量氯胺酮联合咪达唑仑和低剂量布比卡因可稳定剖宫产产妇的血流动力学并延长术后镇痛时间,且无明显副作用。